Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: Egyesült Államok2. fázis

Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis

A legfontosabb adatok

Ki végzi
Yale University
Hol
West Haven (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Fázis
2. fázis
Résztvevők
84 fő, tervezett
Kezdés
2026. nov. 1.
Várható befejezés
2027. júl. 31.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
A vizsgált kezelések
  • inulin
  • Maltodextrin (Placebo)
A regiszteradat frissítve
2026. július 7.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults aged 40 or older with knee osteoarthritis and knee pain. They must be patients of the VA Connecticut Healthcare System.

Életkor
40 years or older
Nem
All sexes
A betegség stádiuma
Knee osteoarthritis, Kellgren-Lawrence grade 2-4 on an X-ray from the past 2 years. Pain of at least 4/10 in one knee in the past week. Knee pain on most days of the past month.
Korábbi kezelés
No antibiotics in the past 6 months. No anti-inflammatory supplements such as turmeric or omega-3 fatty acids in the past 30 days. No investigational drug in the past 30 days.

A részvétel fő kizáró okai

  • Pre-diabetes or diabetes (Type 1 or Type 2)
  • Current use of medicines that strongly affect gut bacteria, such as proton pump inhibitors, disease-modifying antirheumatic drugs or GLP-1 receptor agonists
  • Current tai chi, acupuncture or yoga for knee osteoarthritis
  • Serious gut disease, such as inflammatory bowel disease or an active stomach ulcer
  • Pregnancy, alcohol use disorder, or allergy to inulin or maltodextrin

A regiszter feltételei, szó szerint

Mind a 22 feltétel megnézéseKevesebb

Ki vehet részt

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study (8 weeks)
  • Male or female, aged ≥ 40 years
  • Established patient in the VA Connecticut Healthcare System
  • At least one knee with pain severity in the past week ≥ 4/10 on numerical rating scale (NRS)
  • Self-reported knee pain on most days of the prior month
  • Diagnosed with knee osteoarthritis (Kellgren-Lawrence grade 2-4 on radiographic imaging within the past 2 years)
  • Ability to take oral powder supplements and willingness to adhere to the inulin/placebo daily regimen
  • Agreement to adhere to lifestyle considerations (see Section 5.3) throughout study duration, including maintenance of current diet, physical activity, and avoidance of new dietary supplements or complementary therapies
  • English-speaking and able to provide informed consent
  • For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to continue such method during study participation

Ki nem vehet részt

  • Participation in another interventional study or use of an investigational drug within the past 30 days
  • Current use of complementary or integrative therapies for knee OA including tai chi, acupuncture or yoga
  • Current use of medications known to significantly impact the gut microbiome (e.g., proton pump inhibitors, disease-modifying antirheumatic drugs, GLP-1 receptor agonists)
  • Known allergy or intolerance to components of the study intervention, including inulin or maltodextrin
  • The presence of significant gastrointestinal disease that may interfere with the intervention or outcomes, such as inflammatory bowel disease or active peptic ulcer disease
  • Any medical, psychological, or behavioral condition that, in the opinion of the investigators, would place the participant at undue risk, interfere with study participation or adherence, or compromise data integrity
  • Current diagnosis of alcohol use disorder
  • Current diagnosis of pre-diabetes (impaired glucose tolerance) or diabetes mellitus (Type 1 or Type 2)
  • Use of antibiotics within the past 6 months
  • Use of anti-inflammatory dietary supplements (e.g., turmeric, omega-3 fatty acids) within the past 30 days
  • Pregnancy

Helyszínek itt: Egyesült Államok

  • VA Connecticut Healthcare System, West Haven CampusWest Haven, Egyesült ÁllamokContact: Evelyn Hsieh, MD, PhDToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

This study will test whether inulin, a type of dietary fiber, can reduce inflammation in older adults with knee osteoarthritis. Inflammation in the body may contribute to both joint pain and the progression of osteoarthritis. Inulin is a prebiotic fiber that may improve gut health and reduce lipopolysaccharide (LPS), a marker of bacterial products in the blood that is linked to inflammation.

A teljes eredeti leírásKevesebb

In this trial, participants with knee osteoarthritis will be randomly assigned to receive either inulin or a placebo (maltodextrin) for 8 weeks. The study will measure changes in blood LPS levels, knee pain, and other markers of inflammation. The goal is to determine whether inulin supplementation can improve pain and reduce inflammation in people with knee osteoarthritis.

A vizsgálat 3 csoportja

  • Placebo (Maltodextrin)Placebo, összehasonlításként

    Participants receive maltodextrin powder in identical sachets. Dose is escalated over 2 weeks to match the dosing schedule of the inulin arms (5 g daily for 3 days, 10 g daily for 4 days, then 15 g daily). Sachets are mixed with food or beverage and taken once daily with the largest meal, for 8 weeks.

    Kezelés: Maltodextrin (Placebo)

  • Inulin 10 g/dayA vizsgált kezelés

    Participants receive inulin powder in identical sachets. Dose is escalated to 10 g daily (5 g daily for 3 days, then 10 g daily for 4 days). After Week 2, participants continue with one 15 g sachet containing a 2:1 blend of inulin and maltodextrin, providing a daily dose of 10 g inulin. Sachets are mixed with food or beverage and taken once daily with the largest meal, for 8 weeks.

    Kezelés: inulin

  • Inulin 15 g/dayA vizsgált kezelés

    Participants receive inulin powder in identical sachets. Dose is escalated to 15 g daily (5 g daily for 3 days, 10 g daily for 4 days, then 15 g daily). Sachets are mixed with food or beverage and taken once daily with the largest meal, for 8 weeks.

    Kezelés: inulin

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Change in LPS With Inulin Supplementation and Its Association With Knee Pain Among Older Adults With Osteoarthritis
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. július 7.